West Pharmaceutical Services, Inc. (WST)
West Pharmaceutical Services, Inc. reported revenue of $3.07B for the fiscal year ended Dec 31, 2025, up 6.3% from $2.89B the year before. Net income was $493.70M, a net margin of 16.1% (prior year: $492.70M). At the end of that fiscal year the company reported total assets of $4.27B and shareholders' equity of $3.18B.
Revenue
$3.07B
+6.3% vs prior year
Net income
$493.70M
Net margin 16.1%
Diluted EPS
$6.79
USD per share
Total assets
$4.27B
At Dec 31, 2025
Equity
$3.18B
At Dec 31, 2025
Shares outstanding
70M
As of Oct 21, 2026
Explore West Pharmaceutical Services, Inc.'s filings
- Revenue by year — annual and quarterly revenue with growth rates
- Income statement & cash flow — profit, margins, EPS and operating cash flow
- Balance sheet — assets, liabilities, equity, cash and debt
- SEC filings — 10-K and 10-Q filings with links to EDGAR
Latest SEC filings
- 10-QFiled Oct 29, 2026
- 10-QFiled Jul 23, 2026
- 10-QFiled Apr 23, 2026
- 10-KFiled Feb 17, 2026
- 10-QFiled Oct 23, 2025
- 10-QFiled Jul 24, 2025
Source: SEC EDGAR XBRL company facts for CIK 105770 (raw data). Most recent filing in this dataset: 10-Q filed Oct 29, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.